{{Rsnum
|rsid=3770748
|Gene=QPCT
|Chromosome=2
|position=37368382
|Orientation=minus
|GMAF=0.2732
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=QPCT
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 2.7 | 23.0 | 74.3
| HCB | 26.3 | 49.6 | 24.1
| JPT | 34.5 | 54.9 | 10.6
| YRI | 2.1 | 40.7 | 57.2
| ASW | 5.3 | 29.8 | 64.9
| CHB | 26.3 | 49.6 | 24.1
| CHD | 19.4 | 59.3 | 21.3
| GIH | 8.9 | 37.6 | 53.5
| LWK | 8.2 | 45.5 | 46.4
| MEX | 1.7 | 27.6 | 70.7
| MKK | 2.6 | 32.1 | 65.4
| TSI | 0.0 | 20.6 | 79.4
| HapMapRevision=28
}}
[[rs3770748]], a SNP in an intron of the [[QPCT]] gene, was studied in a population of ~200 Chinese [[osteoporosis]] patients. Heterozygotes appeared to be at higher risk than either homozygote, and the association was statistically strongest in post-menopausal women. {{PMID|17687619}}

{{PMID|19150398|OA=1
}} Quantitative trait loci, genes, and polymorphisms that regulate bone mineral density in mouse.

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}